|
US5290798A
(en)
|
1991-09-30 |
1994-03-01 |
Merck Frosst Canada, Inc. |
(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
US5308850A
(en)
|
1991-09-30 |
1994-05-03 |
Merck Frosst Canada, Inc. |
(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
|
|
JPH06145150A
(ja)
|
1992-11-09 |
1994-05-24 |
Kyowa Hakko Kogyo Co Ltd |
イミダゾール誘導体
|
|
KR20000057137A
(ko)
|
1996-11-19 |
2000-09-15 |
스티븐 엠. 오드레 |
아릴 및 헤테로아릴로 치환된 융합 피롤 항염증제
|
|
WO1998022452A1
(en)
|
1996-11-19 |
1998-05-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Benzofuran derivatives
|
|
US6172084B1
(en)
|
1997-06-19 |
2001-01-09 |
Sepracor, Inc. |
Quinoline-indole antimicrobial agents, uses and compositions related thereto
|
|
ATE499365T1
(de)
|
1997-10-24 |
2011-03-15 |
Nissan Chemical Ind Ltd |
Sulfamoyl-verbindungen und bakterizide für landwirtschaft oder gartenbau
|
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902459D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
GB9902453D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
AU1215701A
(en)
|
1999-10-22 |
2001-05-08 |
Merck & Co., Inc. |
Pharmaceuticals for treating obesity
|
|
AU2001280187A1
(en)
|
2000-08-28 |
2002-03-13 |
Toray Industries, Inc. |
Cyclic amine derivatives
|
|
KR100823908B1
(ko)
|
2000-10-20 |
2008-04-21 |
바이오비트럼 에이비(피유비엘) |
2-, 3-, 4-, 또는 5-치환-ｎ1-(벤젠술포닐)인돌 및 이의치료 용도
|
|
JP4184077B2
(ja)
|
2000-11-02 |
2008-11-19 |
ワイス |
５−ヒドロキシトリプトアミン−６リガンドとしての１−アリールまたは１−アルキルスルホニル−ヘテロシクリルベンザゾール
|
|
US6503907B2
(en)
*
|
2000-11-28 |
2003-01-07 |
Hoffmann-La Roche Inc. |
Indole and dihydroindole derivatives
|
|
WO2002051837A2
(en)
|
2000-12-22 |
2002-07-04 |
Wyeth |
Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
|
|
US7560586B2
(en)
|
2002-03-27 |
2009-07-14 |
Smithkline Beecham Corporation |
Acid and ester compounds and methods of using the same
|
|
IL165863A0
(en)
|
2002-06-24 |
2006-01-15 |
Schering Corp |
Indole derivatives useful as histamine H3 antagonists
|
|
ES2228267B1
(es)
|
2003-07-30 |
2006-07-01 |
Laboratorios Del Dr. Esteve, S.A. |
Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
|
|
GB0323845D0
(en)
*
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
|
WO2005077122A2
(en)
|
2004-02-11 |
2005-08-25 |
Irm Llc |
Compounds and compositions as lxr modulators
|
|
WO2005085188A2
(en)
|
2004-03-02 |
2005-09-15 |
Compass Pharmaceuticals Llc |
Compounds and methods for anti-tumor therapy
|
|
DE602005015962D1
(de)
*
|
2004-05-03 |
2009-09-24 |
Hoffmann La Roche |
Indolylderivate als liver-x-rezeptormodulatoren
|
|
WO2005113499A1
(ja)
*
|
2004-05-20 |
2005-12-01 |
Sankyo Company, Limited |
インドール化合物
|
|
EP1773781A2
(en)
*
|
2004-08-03 |
2007-04-18 |
Wyeth |
Indazoles useful in treating cardiovascular diseases
|
|
WO2007134169A2
(en)
|
2006-05-10 |
2007-11-22 |
Nuada, Llc |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
US20080319044A1
(en)
|
2004-11-01 |
2008-12-25 |
Nuada, Llc |
Compounds and Methods of Use Thereof
|
|
WO2006109633A1
(ja)
*
|
2005-04-07 |
2006-10-19 |
Daiichi Sankyo Company, Limited |
置換インドール化合物
|
|
FR2886293B1
(fr)
*
|
2005-05-30 |
2007-08-24 |
Fournier S A Sa Lab |
Nouveaux composes de l'indoline
|
|
TW200745031A
(en)
*
|
2005-10-13 |
2007-12-16 |
Merck & Co Inc |
Acyl indoles, compositions containing such compounds and methods of use
|
|
EP1965862A2
(en)
|
2005-12-21 |
2008-09-10 |
Schering Corporation |
Combination of an h3 antagonist/inverse agonist and an appetite suppressant
|
|
EP2041131B1
(en)
|
2006-07-06 |
2011-09-28 |
Abbott Healthcare Products B.V. |
Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition
|
|
TW200825054A
(en)
|
2006-10-18 |
2008-06-16 |
Wyeth Corp |
Quinoline compounds
|
|
US8507469B2
(en)
|
2007-03-23 |
2013-08-13 |
Abbott Gmbh & Co. Kg |
Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
AU2008234017B2
(en)
|
2007-03-30 |
2011-09-22 |
F. Hoffmann-La Roche Ag |
Imidazolidinone derivatives
|
|
GB0708141D0
(en)
*
|
2007-04-26 |
2007-06-06 |
Syngenta Participations Ag |
Improvements in or relating to organic compounds
|
|
WO2009032116A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
2, 3-substituted indole derivatives for treating viral infections
|
|
ATE541845T1
(de)
|
2007-08-29 |
2012-02-15 |
Schering Corp |
2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
|
|
US8377928B2
(en)
|
2007-11-16 |
2013-02-19 |
Merck Sharp & Dohme Corp. |
3-aminosulfonyl substituted indole derivatives and methods of use thereof
|
|
MX2010005356A
(es)
|
2007-11-16 |
2010-05-27 |
Schering Corp |
Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
|
|
WO2010010186A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
|
EP2210891A1
(en)
|
2009-01-26 |
2010-07-28 |
Domain Therapeutics |
New adenosine receptor ligands and uses thereof
|
|
EP2245936A1
(en)
|
2009-04-27 |
2010-11-03 |
Bayer CropScience AG |
Use of 4-aza indole derivatives for the reduction of mycotoxin contamination
|
|
KR20120049214A
(ko)
|
2009-06-08 |
2012-05-16 |
악셀레론 파마 인코포레이티드 |
발열성 지방세포를 증가시키는 방법
|
|
WO2013012649A1
(en)
|
2011-07-15 |
2013-01-24 |
Glaxosmithkline Llc |
Azaindole compounds and methods for treating hiv
|
|
WO2013028999A1
(en)
|
2011-08-24 |
2013-02-28 |
The Trustees Of Columbia University In The City Of New York |
Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
|
|
RU2672468C1
(ru)
|
2011-12-22 |
2018-11-15 |
Конекшис Лайф Сайенсиз Пвт. Лтд. |
Производные аза-адамантанов и их применение
|
|
KR20130142801A
(ko)
|
2012-06-20 |
2013-12-30 |
안국약품 주식회사 |
１１β－ＨＳＤ１ 효소의 억제활성을 갖는 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
US9376420B2
(en)
*
|
2012-10-25 |
2016-06-28 |
Yuhan Corporation |
4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
|
|
WO2014085453A2
(en)
|
2012-11-29 |
2014-06-05 |
The Scripps Research Institute |
Small molecule lxr inverse agonists
|
|
CN105209039B
(zh)
*
|
2013-03-15 |
2018-06-22 |
百时美施贵宝公司 |
Lxr调节剂
|
|
EP2990403A1
(en)
|
2014-08-29 |
2016-03-02 |
Novartis Tiergesundheit AG |
Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
|
|
CA2968299A1
(en)
|
2014-11-18 |
2016-05-26 |
Rutgers, The State University Of New Jersey |
Novel mitochondrial uncouplers for treatment of metabolic diseases and cancer
|
|
AR103232A1
(es)
|
2014-12-22 |
2017-04-26 |
Bristol Myers Squibb Co |
ANTAGONISTAS DE TGFbR
|
|
FR3037959B1
(fr)
|
2015-06-23 |
2017-08-04 |
Servier Lab |
Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US10227315B2
(en)
|
2016-05-18 |
2019-03-12 |
Rutgers, The State University Of New Jersey |
Mitochondrial uncouplers for treatment of metabolic diseases and cancer
|
|
UY37659A
(es)
*
|
2017-04-10 |
2018-10-31 |
Phenex Fxr Gmbh |
Moduladores del receptor x del hígado (lxr)
|
|
TWI683808B
(zh)
*
|
2017-07-18 |
2020-02-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有胺或(硫)醯胺之lxr調節劑
|
|
LT3796975T
(lt)
|
2018-05-22 |
2023-12-11 |
Orsobio, Inc. |
Sulfonilaminobenzamido dariniai
|
|
TWI748194B
(zh)
|
2018-06-28 |
2021-12-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有雙環核心部分之新穎lxr調節劑
|
|
US20200397807A1
(en)
|
2019-06-18 |
2020-12-24 |
MitoPower, LLC |
Nicotinyl riboside compounds and their uses
|
|
EP4611746A1
(en)
|
2022-11-03 |
2025-09-10 |
OrsoBio, Inc. |
Lxr modulators with bicyclic core moiety for treating dyslipidemias
|